Navigating the AI 'hype cycle': Bayer, Daiichi Sankyo and argenx leaders on implementing AI in biopharma marketing

No longer a far-off futuristic idea, artificial intelligence technology has seen its popularity skyrocket in recent years. Its usage continues to grow rapidly and exponentially: According to IBM’s most recent Global AI Adoption Index report, around 42% of large businesses are actively using AI, up from 35% just one year prior and 31% the year before that.